digital currency atm Top Reviews

A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)Nine of the top ten stocks rose, while the A50ETF Huabao (159596) rose linearly, and Contemporary Amperex Technology Co., Limited rose by nearly 3%. On December 11th, near midday, driven by big finance, the three indexes rose rapidly. By midday, the A50ETF Huabao (159596) rose by 0.9%, with a turnover of 83.4 million yuan. In terms of constituent stocks, 9 of the top ten awkward stocks rose. In terms of rising, Contemporary Amperex Technology Co., Limited led the rise by nearly 3%, and China Ping An, CITIC Securities and other stocks followed suit; In terms of decline, only Hengrui Pharma fell. According to the strategists of SDIC Securities, the strategic elements to promote the stock market upward from the perspective of "liquidity" are complete. The market based on the "fundamental" perspective is to pay attention to the recovery of M1 for more than two consecutive months. Looking back at history, after M1 rebounded from the bottom for more than two consecutive months, the market sector represented by consumption and pro-cyclical sectors will start pricing, and then a style switch for fundamental pricing may be formed.Spring Festival travel rush's first day train tickets will be sold on 31st of this month. The student booking service was launched today. It was learned from China State Railway Group Co.,Ltd. today (12th) that Spring Festival travel rush will be launched on 14th of January next year in 2025, and Spring Festival travel rush's first day train tickets will be sold on 31st of this month. In view of students booking tickets during Spring Festival travel rush, Railway 12306 launched a new function today.

India's SENSEX30 index opened 0.06% lower at 81,476.76 points. Among the constituent stocks, State Power of India opened 0.79% higher, Mahengda Information Technology rose 0.56%, and Tata Motors rose 0.5%; In terms of decline, HDFC BANK opened 0.74% lower, Bharti Telecom fell 0.68%, and Unilever of India fell 0.53%.By 11:30, 100 stocks in the two cities had daily limit.Xia Yiping's internal letter was alleged to have been copied from Weilai Li Bin. Xia Yiping, CEO of Jiyue, released an internal letter on the afternoon of 11th, acknowledging that the company was encountering difficulties and needed to adjust immediately. Some netizens pointed out that part of Xia Yiping's internal letter copied the internal letter of Weilai Li Bin in 2023. Xia Yiping's internal letter mentioned that the following four things must be done well in the new entrepreneurial period: 1. Adhere to the long-term investment in core technologies to maintain the leading edge; 2. Strengthen sales and service capacity building to cope with fierce market competition; 3. Merge departments and posts with duplicate functions and change inefficient internal workflow; 4. Reduce projects that cannot improve financial performance in the short term. In 2023, Li Bin's internal letter also mentioned: ensure long-term investment in core key technologies and maintain the leading edge of technology and products; Ensure that sales and service capabilities can cope with fierce market competition; Ensure that 9 core products of 3 brands are listed as scheduled; Organize efficiency improvement, merge redundant departments and posts, change inefficient internal workflow and division of labor, and cancel inefficient posts; Improve the efficiency of resources, postpone and reduce the project investment that can not improve the company's financial performance within 3 years. (Sina Technology)

Sumeida: The first batch of production equipment was shipped out of Malaysia's sunscreen series products project. According to Sumeida, in the fourth quarter of 2024, Sumeida went all out to sprint the annual target and task, and the project of Malaysia's sunscreen series products with an annual output of 10,000 tons cooperated with Nanjing Kesi Chemical Co., Ltd. realized the first batch of production equipment delivery, adding more help to escort domestic customers to the sea. The equipment shipped this time includes storage tanks, reaction vessels, distillation columns, dryers, etc. The total cargo volume is estimated to be nearly 80,000 cubic meters, which will be used for the production of various sunscreens in customers' factories in Malaysia. In recent years, technology companies have kept up with the upsurge of enterprises going to sea in China, and are committed to providing comprehensive service solutions for Chinese enterprises going to sea. In the first three quarters of this year, the cumulative amount of mechanical and electrical equipment shipped by technology companies increased by 363% year-on-year.India's SENSEX30 index opened 0.06% lower at 81,476.76 points. Among the constituent stocks, State Power of India opened 0.79% higher, Mahengda Information Technology rose 0.56%, and Tata Motors rose 0.5%; In terms of decline, HDFC BANK opened 0.74% lower, Bharti Telecom fell 0.68%, and Unilever of India fell 0.53%.A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)